Andrea Nicolini

Summary

Affiliation: University of Pisa
Country: Italy

Publications

  1. pmc Defining the critical hurdles in cancer immunotherapy
    Bernard A Fox
    Earle A, Chiles Research Institute, Robert W, Franz Research Center, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA
    J Transl Med 9:214. 2011
  2. ncbi request reprint Cytokines in breast cancer
    A Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Cytokine Growth Factor Rev 17:325-37. 2006
  3. ncbi request reprint Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC)
    A Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, Pisa 56126, Italy
    Biomed Pharmacother 58:447-50. 2004
  4. ncbi request reprint Cancer stem cells: perspectives of new therapeutical approaches for breast cancer
    A Nicolini
    Department of Internal Medicine, University of Pisa, Pisa, Italy
    Front Biosci (Schol Ed) 3:1486-99. 2011
  5. ncbi request reprint An immunotherapy schedule in endocrine-dependent metastatic breast cancer: correlation between clinical course and immunologic parameters
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, 56126 Pisa Italy
    J Immunother 28:276-9. 2005
  6. ncbi request reprint Beta-interferon and interleukin-2 prolong more than three times the survival of 26 consecutive endocrine dependent breast cancer patients with distant metastases: an exploratory trial
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Biomed Pharmacother 59:253-63. 2005
  7. ncbi request reprint Additional 5-FU-LV significantly increases survival in gastrointestinal cancer
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Pisa, Italy
    Front Biosci (Elite Ed) 3:1475-82. 2011
  8. ncbi request reprint Biomolecular markers of breast cancer
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Italy
    Front Biosci 11:1818-43. 2006
  9. ncbi request reprint Metastatic breast cancer: an updating
    A Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Biomed Pharmacother 60:548-56. 2006
  10. pmc Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Pisa, Italy
    BMC Cancer 6:269. 2006

Collaborators

Detail Information

Publications59

  1. pmc Defining the critical hurdles in cancer immunotherapy
    Bernard A Fox
    Earle A, Chiles Research Institute, Robert W, Franz Research Center, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA
    J Transl Med 9:214. 2011
    ..Each of these hurdles can significantly delay clinical translation of promising advances in immunotherapy yet if overcome, have the potential to improve outcomes of patients with cancer...
  2. ncbi request reprint Cytokines in breast cancer
    A Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Cytokine Growth Factor Rev 17:325-37. 2006
    ....
  3. ncbi request reprint Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC)
    A Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, Pisa 56126, Italy
    Biomed Pharmacother 58:447-50. 2004
    ..So it can be an useful option before or after the use of other single or combined potentially active chemotherapeutic agents...
  4. ncbi request reprint Cancer stem cells: perspectives of new therapeutical approaches for breast cancer
    A Nicolini
    Department of Internal Medicine, University of Pisa, Pisa, Italy
    Front Biosci (Schol Ed) 3:1486-99. 2011
    ..Here all these novel approaches related to breast cancer stem cells are described...
  5. ncbi request reprint An immunotherapy schedule in endocrine-dependent metastatic breast cancer: correlation between clinical course and immunologic parameters
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, 56126 Pisa Italy
    J Immunother 28:276-9. 2005
    ....
  6. ncbi request reprint Beta-interferon and interleukin-2 prolong more than three times the survival of 26 consecutive endocrine dependent breast cancer patients with distant metastases: an exploratory trial
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Biomed Pharmacother 59:253-63. 2005
    ..Hormone immuno-therapy was given in an outpatient setting and was very well tolerated. These data suggest that immuno-therapy plays an important role in endocrine-dependent metastatic breast cancer...
  7. ncbi request reprint Additional 5-FU-LV significantly increases survival in gastrointestinal cancer
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Pisa, Italy
    Front Biosci (Elite Ed) 3:1475-82. 2011
    ..9, 95 % C.I.: 2.0-39.9, p = 0.004) in the study group and in matched controls respectively. These findings suggest a relevant improvement in the outcome of this population by an intermittent and prolonged cytostatic effect with 5-FU-LV...
  8. ncbi request reprint Biomolecular markers of breast cancer
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Italy
    Front Biosci 11:1818-43. 2006
    ..In conclusion, biomolecular markers are improving understanding of biology and management of breast cancer...
  9. ncbi request reprint Metastatic breast cancer: an updating
    A Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Biomed Pharmacother 60:548-56. 2006
    ..This article reports on recent advances on metastatic breast cancer. Detection, prognostic factors, predictors of response to therapy and therapy, with particular regard to targeted therapies, were examined...
  10. pmc Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Pisa, Italy
    BMC Cancer 6:269. 2006
    ..As high sensitivity and specificity and different cut-off values have been reported for mucin-like carcinoma associated antigen (MCA), we compared MCA with the above mentioned tumour markers and MCA-CA15.3 with the CEA-TPA-CA15.3 panel...
  11. doi request reprint Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Italy
    Arch Surg 145:1177-83. 2010
    ..Intensive risk-adjusted follow-up leads to improved resectability of tumor recurrences and better overall survival among patients who have undergone surgery for colorectal cancer...
  12. ncbi request reprint Stem cells: their role in breast cancer development and resistance to treatment
    A Nicolini
    Department of Internal Medicine, University of Pisa, Italy
    Curr Pharm Biotechnol 12:196-205. 2011
    ..The reasons for CSC resistance to chemotherapy, hormone therapy and radiotherapy also have been examined and they opened new scenarios for cancer therapy...
  13. doi request reprint Immunotherapy prolongs the serum CEA-TPA-CA15.3 lead time at the metastatic progression in endocrine-dependent breast cancer patients: a retrospective longitudinal study
    A Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Cancer Lett 263:122-9. 2008
    ..05). The CEA-TPA-CA15.3 tumour marker panel accurately predicted metastatic disease progression and immunotherapy significantly prolonged the CEA-TPA-CA15.3 lead time. This can be used for anticipating salvage treatment in these patients...
  14. doi request reprint A new pharmacological approach to gastrointestinal cancer at high risk of relapse based on maintenance of the cytostatic effect
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, 56126, Pisa, Italy
    Tumour Biol 31:523-32. 2010
    ..8% and 40.1%, respectively. These findings suggest that this new pharmacological approach based on the long-term maintenance of a cytostatic effect with 5-FU-LV can produce a relevant improvement in the outcome of this population...
  15. ncbi request reprint Utility of a serum tumour marker panel in the post-operative follow-up of breast cancer patients with equivocal conventional radiological examinations
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Pisa, Italy
    Tumour Biol 24:275-80. 2003
    ..Clinical data of 427 breast cancer patients submitted to an intensive follow-up after mastectomy between January 1986 and December 2000 were retrospectively reviewed...
  16. ncbi request reprint Relationship of cellular immunity, cytokines and CRP with clinical course in breast cancer patients with endocrine-dependent distant metastases treated with immunotherapy
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Cancer Lett 251:330-8. 2007
    ..Furthermore, these results demonstrate that different changes of proinflammatory cytokines, CRP and inhibiting factors are consistent with associated clinical benefit or with disease progression, respectively...
  17. ncbi request reprint Long-term monitoring of cell-mediated immunity in disease-free breast cancer patients: a preliminary retrospective study
    A Nicolini
    Department of Internal Medicine, University of Pisa, Italy
    Biomed Pharmacother 56:339-44. 2002
    ..The prolonged disease-free interval observed in the 34 N- and 11 N+ breast cancer patients can be correlated with the restoration of the normal state of cell-mediated immunity...
  18. ncbi request reprint Conventional and new emerging prognostic factors in breast cancer: an update
    Andrea Nicolini
    University of Pisa, Department of Internal Medicine, Via Roma 67, 56126 Pisa, Italy
    Biomark Med 1:525-40. 2007
    ..So far, different gene-expression patterns with different prognoses have been identified but methodological problems remain to be solved prior to routine use...
  19. ncbi request reprint "Tumour marker guided" salvage treatment prolongs survival of breast cancer patients: final report of a 7-year study
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Biomed Pharmacother 57:452-9. 2003
    ..3) tumour marker panel is sensitive enough for significantly anticipating salvage treatment and prolonging survival of relapsing breast cancer patients...
  20. doi request reprint CXCL10 and CCL2 chemokine serum levels in patients with hepatitis C associated with autoimmune thyroiditis
    Alessandro Antonelli
    Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy
    J Interferon Cytokine Res 29:345-51. 2009
    ....
  21. doi request reprint Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate
    Paola Ferrari
    Department of Oncology, University of Pisa, Pisa, Italy
    Biomed Pharmacother 66:414-8. 2012
    ..In conclusion, these data suggest that ferrous bisglycinate chelate has similar efficacy and likely lower GI toxicity than ferrous sulphate given at the conventional dose of 105 mg per day for the same time...
  22. pmc Does large needle aspiration biopsy add pain to the thyroid nodule evaluation?
    Angelo Carpi
    Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
    PLoS ONE 8:e58016. 2013
    ..Large needle aspiration biopsy after fine needle aspiration biopsy does not add any discomfort or pain and therefore in light of the demonstrable benefits, should be included in clinical algorithms for the evaluation of thyroid nodules...
  23. pmc Are risk factors common to thyroid cancer and nodule? A forty years observational time-trend study
    Angelo Carpi
    Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
    PLoS ONE 7:e47758. 2012
    ..810). This finding suggests that pathogenic risk factors and more sensitive diagnostic technologies did not differentially affect the incidence of TN and TC...
  24. doi request reprint Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications
    Angelo Carpi
    Department of Reproduction and Ageing, University of Pisa, Pisa, Italy
    J Cell Physiol 224:612-9. 2010
    ..This can be rectified with large needle aspiration biopsy (LNAB) techniques and is exemplified by the favorable performance of galectin-3 determinations on LNAB specimens...
  25. ncbi request reprint The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha
    Alessandro Antonelli
    Department of Internal Medicine, University of Pisa, Italy
    Clin Exp Rheumatol 29:S17-22. 2011
    ..The aims of the study were to evaluate serum levels of IL-6 in MC+HCV patients and to correlate this parameter with the presence of AT and with circulating levels of TNF-α...
  26. doi request reprint Large needle aspiration biopsy histology for preoperative selection of Hürthle cell thyroid nodules
    Angelo Carpi
    Department of Reproduction and Ageing, University of Pisa, Pisa, Italy
    Histopathology 59:892-6. 2011
    ....
  27. pmc The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy
    A Nicolini
    Department of Internal Medicine, University of Pisa, Italy
    Br J Cancer 79:1443-7. 1999
    ..3 tumour marker panel has a high value in selecting those patients with bone metastases, or at high risk of developing clinically-evident bone metastases, among the large number of subjects with equivocal BS...
  28. pmc Defective generation and maturation of dendritic cells from monocytes in colorectal cancer patients during the course of disease
    Giulia Orsini
    Laboratory of Immunology, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67, Pisa 56126, Italy
    Int J Mol Sci 14:22022-41. 2013
    ..This work sheds light on a dendritic cell-based tumor immune escape mechanism that could be useful for the development of more effective immunotherapeutic strategies. ..
  29. doi request reprint Targeted therapies of metastatic breast cancer: relationships with cancer stem cells
    Paola Ferrari
    Unit of Oncology 1, Department of Oncology, Transplants and New Technologies in Medicine, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Biomed Pharmacother 67:543-55. 2013
    ....
  30. doi request reprint Galectin-3 detection on large-needle aspiration biopsy improves preoperative selection of thyroid nodules: a prospective cohort study
    Angelo Carpi
    Department of Reproduction and Ageing, University of Pisa, Pisa, Italy
    Ann Med 42:70-8. 2010
    ..New techniques of improving diagnostic reliability of thyroid nodules are needed...
  31. doi request reprint Immune manipulation of advanced breast cancer: an interpretative model of the relationship between immune system and tumor cell biology
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Pisa, Italy
    Med Res Rev 29:436-71. 2009
    ..Tumor growth, defective immunorecognition and immunosuppression are the three principal effects considered responsible for immune evasion...
  32. doi request reprint Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis
    Alessandro Antonelli
    Metabolism Unit, Department of Medicine and CNR Institute of Clinical Physiology, University of Pisa School of Medicine, I 56100 Pisa, Italy
    J Clin Endocrinol Metab 96:1859-63. 2011
    ..Recently, CXCL9 and CXCL11 have been shown to be involved in autoimmune thyroid disorders; however, no data are present about CXCL9 and CXCL11 circulating levels in thyroid autoimmunity...
  33. ncbi request reprint Percutaneous large-needle aspiration biopsy histology of palpable thyroid nodules: technical and diagnostic performance
    A Carpi
    Department of Reproduction and Ageing, University Hospital, Pisa, Italy
    Histopathology 51:249-57. 2007
    ..To report original and review existing data on safety and performance of large-needle aspiration biopsy (LNAB) histology in the preoperative selection of palpable thyroid nodule...
  34. ncbi request reprint Advanced breast cancer: an update and controversies on diagnosis and therapy
    A Nicolini
    Department of Internal Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Biomed Pharmacother 57:439-46. 2003
    ..Furthermore, the options and associations of the drug therapy available for treatment of advanced breast cancer have been reviewed...
  35. ncbi request reprint Cytokines in the management of high risk or advanced breast cancer: an update and expectation
    A Carpi
    Department of Reproduction and Ageing, 56126 Pisa, Italy
    Curr Cancer Drug Targets 9:888-903. 2009
    ..If this immunotherapy prolongs survival of endocrine dependent metastatic breast cancer patients, IL-2 and IFNbeta can also be evaluated as adjuvant treatment of patients with positive estrogen receptors...
  36. ncbi request reprint Thyroid nodule evaluation: what have we really learned from recent clinical guidelines?
    A Carpi
    Department of Reproduction and Ageing, University of Pisa, Italy
    Biomed Pharmacother 60:393-5. 2006
    ....
  37. ncbi request reprint Vascular endothelial growth factor (VEGF) and other common tissue prognostic indicators in breast cancer: a case-control study
    A Nicolini
    Department of Internal Medicine, University of Pisa, Italy
    Int J Biol Markers 19:275-81. 2004
    ..018 to 0.001). In conclusion, tissue VEGF does not seem a suitable candidate to replace conventional histological and other common biological prognostic factors in breast cancer...
  38. pmc Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients
    A Nicolini
    Institute of 2nd Medical Clinic, University of Pisa, Italy
    Br J Cancer 64:154-8. 1991
    ..Contemporaneous measurement of serum CEA levels only slightly increases sensitivity and positive predictive value of TPA-CA15-3 combination...
  39. pmc The role of tumour markers in improving the accuracy of conventional chest X-ray and liver echography in the post-operative detection of thoracic and liver metastases from breast cancer
    A Nicolini
    Department of Internal Medicine, University of Pisa, Pisa, Italy
    Br J Cancer 83:1412-7. 2000
    ..3 tumour marker panel has a high value for selecting those patients at high risk of developing clinically evident pulmonary or liver metastases from amongst those subjects with equivocal CXR or equivocal LE...
  40. ncbi request reprint Postoperative follow-up of breast cancer patients: overview and progress in the use of tumor markers
    A Nicolini
    Department of Internal Medicine, Oncological Consulting Room and Department of Reproduction and Aging, University of Pisa, Italy
    Tumour Biol 21:235-48. 2000
    ..It is hoped that these data will stimulate further trials including TAA in the follow-up of breast cancer patients...
  41. doi request reprint Thyroid fine needle aspiration: how to improve clinicians' confidence and performance with the technique
    A Carpi
    Department of Reproduction and Ageing, University Hospital, Ospedale Santa Chiara, Via Roma, 67, 56126 Pisa, Italy
    Cancer Lett 264:163-71. 2008
    ..Therefore, we propose that clinical practice guidelines reflect these adjuvant techniques to thyroid FNA in order to improve selection criteria for thyroid nodule surgery...
  42. ncbi request reprint Clinical and laboratory patterns during immune stimulation in hormone responsive metastatic breast cancer
    Andrea Nicolini
    Department of Oncology, University of Pisa, Pisa, Italy Electronic address
    Biomed Pharmacother 68:171-8. 2014
    ..5months, respectively; P=0.001). These data show laboratory evidence of the effect of immunotherapy as well as that of hormone resistance occuring concomitantly with a laboratory pattern compatible with immune inhibition. ..
  43. ncbi request reprint Large needle percutaneous aspiration biopsy of the testicle in men with nonobstructive azoospermia: technical performance
    Angelo Carpi
    Department of Reproduction and Aging, University of Pisa, Pisa, Italy
    Biomed Pharmacother 60:557-60. 2006
    ..needle seemed to offer the best performance in the larger testicles, while in the medium and lower sized testicles the smaller 22 g. needle gave results comparable to or slightly better than the other larger needles...
  44. pmc Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology
    A Carpi
    Department of Reproduction, University of Pisa, Pisa 56024, Italy
    Br J Cancer 95:204-9. 2006
    ..6, 97.2 and 95.3%, respectively. In conclusion, LNAB plus galectin-3 expression analysis when applied preoperatively to selected thyroid nodules candidate to surgery can potentially reduce unnecessary thyroid resections...
  45. ncbi request reprint Malnutrition, anorexia and cachexia in cancer patients: A mini-review on pathogenesis and treatment
    Andrea Nicolini
    Unit of Oncology 1, Department of Oncology, Transplants and New Technologies in Medicine, Azienda Ospedaliera Universitaria Pisana, Via Roma 67, 56126 Pisa, Italy
    Biomed Pharmacother 67:807-17. 2013
    ..Treatment includes pharmaceutical and nutritional interventions...
  46. ncbi request reprint An iron regulatory gene signature in breast cancer: more than a prognostic genetic profile?
    Andrea Nicolini
    Department of Internal Medicine, University of Pisa, Italy
    Future Oncol 8:131-4. 2012
    ..Consistent with this, it is reasonable to imagine that the iron-export and the iron-import gene dyads will be considered potential targets for treatment of breast cancer patients expressing the IRGS genes...
  47. ncbi request reprint Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis
    Alessandro Antonelli
    Department of Internal Medicine, University of Pisa School of Medicine, I 56100 Pisa, Italy
    Metabolism 57:1270-7. 2008
    ..Future studies in larger series will be needed to evaluate the potential usefulness of serum CXCL10 and CCL2 determination as a prognostic marker in the follow-up of MC patients, also in relation to the presence of AT...
  48. ncbi request reprint Large-needle aspiration biopsy for the preoperative selection of palpable thyroid nodules diagnosed by fine-needle aspiration as a microfollicular nodule or suspected cancer
    A Carpi
    Department of Reproduction and Aging, University of Pisa, Italy
    Am J Clin Pathol 113:872-7. 2000
    ..These data indicate that histologic examination of the LNAB specimen can be used for preoperative selection of thyroid nodules diagnosed by FNA as a microfollicular nodule or suspected cancer...
  49. ncbi request reprint Serum tumor markers in the management of ovarian, endometrial and cervical cancer
    Angiolo Gadducci
    Division of Gynecology and Obstetrics, Department of Procreative Medicine and Child Development, University of Pisa, Via Roma 67, 56127, Pisa, Italy
    Biomed Pharmacother 58:24-38. 2004
    ..Elevated CA 125 levels can be often detected in patients with cervical adenocarcinoma. The future for tumor marker research is represented by the emerging technologies of transcriptional profiling and proteomics...
  50. ncbi request reprint Large needle aspiration biopsy results of palpable thyroid nodules diagnosed by fine-needle aspiration as a microfollicular nodule with atypical cells or suspected cancer
    Angelo Carpi
    Department of Reproduction, University of Pisa, Spedali Santra Chiara, Via Roma 67, 56126, Italy
    Biomed Pharmacother 58:351-5. 2004
    ..0007). These data suggest that LNAB can be used for the preoperative selection of the palpable thyroid nodules diagnosed by FNA as a microfollicular nodule with atypical cells or suspected cancer...
  51. ncbi request reprint Nonpalpable thyroid carcinoma: clinical controversies on preoperative selection
    Angelo Carpi
    Department of Reproduction and Aging, University of Pisa, Pisa, Italy
    Am J Clin Oncol 26:232-5. 2003
    ..the natural history of a small thyroid carcinoma, as well as the accuracy of ultrasound and ultrasound-guided FNA in the specific institution...
  52. ncbi request reprint Large-needle aspiration biopsy for the preoperative selection of follicular adenoma diagnosed by fine-needle aspiration as a microfollicular nodule or suspected cancer
    Angelo Carpi
    Department of Reproduction and Aging, University of Pisa, Pisa, Italy
    Am J Clin Oncol 25:209-12. 2002
    ....
  53. ncbi request reprint Controversies in diagnostic approaches to the indeterminate follicular thyroid nodule
    A Carpi
    Internal Medicine Department, University of Pisa Medical School, Pisa, Italy
    Biomed Pharmacother 59:517-20. 2005
    ..Among the techniques that may improve preoperative diagnostic accuracy are large needle aspiration biopsy and immunohistochemistry for galectin-3...
  54. ncbi request reprint Aspiration needle biopsy in preoperative selection of thyroid nodules defined at fine-needle aspiration as microfollicular lesions
    A Carpi
    Department of Reproduction and Aging, University of Pisa, Italy
    Am J Clin Oncol 22:65-9. 1999
    ....
  55. pmc Prolonged survival by 'early' salvage treatment of breast cancer patients: a retrospective 6-year study
    A Nicolini
    Institute of 2nd Medical Clinic, University of Pisa, Italy
    Br J Cancer 76:1106-11. 1997
    ..Randomized prospective trials must be encouraged to confirm these data and to better evaluate the effect on the disease-free survival (DFS) and overall survival (OS) of 'early' salvage treatment protocols...
  56. ncbi request reprint Total parathyroidectomy without autotransplantation for the treatment of secondary hyperparathyroidism associated with chronic kidney disease: clinical and laboratory long-term follow-up
    M Puccini
    Department of Surgery, AOUP, S Chiara Hospital, Pisa, Italy
    Biomed Pharmacother 64:359-62. 2010
    ..tPTX should be considered a safe and successful procedure for the treatment of severe secondary hyperparathyroidism associated with chronic kidney disease...
  57. ncbi request reprint From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodules
    Alessandra Gasbarri
    Department of Pathology, St Andrea University Hospital, Rome, Italy
    Biomed Pharmacother 58:356-9. 2004
    ..The rationale of this new diagnostic approach, the possibility to improve its performance in selected cases by using large needle aspiration biopsy (LNAB) together with technical and operative details are presented and discussed...
  58. ncbi request reprint Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET
    Carlo Capirci
    Radiotherapy Department, S Maria della Misericordia Rovigo Hospital, ASL 18, Rovigo, Italy
    Biomed Pharmacother 58:451-7. 2004
    ....
  59. ncbi request reprint Presence of a functional TSH receptor on human erythrocytes
    Silvana Balzan
    Institute of Clinical Physiology, CNR, Via Moruzzi 1, Pisa 56124, Italy
    Biomed Pharmacother 61:463-7. 2007
    ..125)I-TSH binding studies and Western blotting data showed the existence of TSHR in the erythrocytes of healthy donors. In conclusion The TSH action on Na(+)/K(+)-ATPase of human erythrocytes can be explained by the presence of TSHR...